PT Indofarma Tbk reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was IDR 169,795.45 million compared to IDR 339,027.45 million a year ago. Net loss was IDR 61,796.49 million compared to IDR 51,182.65 million a year ago.

Basic loss per share from continuing operations was IDR 19.94 compared to IDR 16.51 a year ago.